Citi: Maintains the McKesson (MCK.US) rating, adjusted from buy to buy rating, and adjusted the target price from $575.00 to $620.00.
Zhitong FinanceApr 30 22:30
McKesson Analyst Ratings
BenzingaApr 30 22:28
Citigroup Adjusts Price Target on McKesson to $620 From $575
MT NewswiresApr 30 19:43
Barclays Reaffirms Their Buy Rating on McKesson (MCK)
TipRanksApr 24 16:46
Buy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract Win
TipRanksApr 24 14:26
Buy Rating Affirmed: McKesson's Strategic Growth Bolstered by OptumRx Contract Win
TipRanksApr 23 00:15
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), McKesson (MCK)
TipRanksApr 16 12:20
Damo: Maintaining the McKesson (MCK.US) rating, adjusted from an increase to an increase in holdings rating, and the target price was adjusted from $522.00 to $548.00.
Zhitong FinanceApr 16 00:41
McKesson Analyst Ratings
BenzingaApr 16 00:39
Morgan Stanley Maintains Overweight on McKesson, Raises Price Target to $548
BenzingaApr 16 00:40
McKesson Analyst Ratings
BenzingaApr 10 23:21
Deutsche Bank Raises McKesson Price Target to $547 From $517, Maintains Buy Rating
MT NewswiresMar 7 23:16
McKesson Analyst Ratings
BenzingaMar 7 01:42
UBS Adjusts McKesson Price Target to $620 From $575, Maintains Buy Rating
MT NewswiresMar 6 23:41
McKesson Analyst Ratings
BenzingaFeb 26 21:44
Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK)
TipRanksFeb 26 20:20
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)
TipRanksFeb 12 18:50
UBS Adjusts McKesson Price Target to $575 From $559, Maintains Buy Rating
MT NewswiresFeb 10 01:19
McKesson Analyst Ratings
BenzingaFeb 9 23:50
McKesson Analyst Ratings
BenzingaFeb 9 00:19
No Data
No Data